These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8719096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Gastrointestinal lymphoma].
    Fischbach W, Daum S.
    Dtsch Med Wochenschr; 2003 Sep 12; 128(37):1899-901. PubMed ID: 12970824
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Advances for the treatment of primary central nervous system lymphoma (review).
    Yamanaka R, Tanaka R.
    Oncol Rep; 2004 Sep 12; 12(3):563-8. PubMed ID: 15289838
    [Abstract] [Full Text] [Related]

  • 9. [Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].
    Soussain C, Hoang-Xuan K, Levy V.
    Bull Cancer; 2004 Feb 12; 91(2):189-92. PubMed ID: 15047459
    [Abstract] [Full Text] [Related]

  • 10. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
    Oestreicher P.
    ONS Connect; 2007 Feb 12; 22(8 Suppl):37-8. PubMed ID: 17824557
    [No Abstract] [Full Text] [Related]

  • 11. Treatment approaches for primary CNS lymphomas.
    Carrabba MG, Reni M, Foppoli M, Chiara A, Franzin A, Politi LS, Villa E, Ciceri F, Ferreri AJ.
    Expert Opin Pharmacother; 2010 Jun 12; 11(8):1263-76. PubMed ID: 20429667
    [Abstract] [Full Text] [Related]

  • 12. [Malignant non-Hodgkin lymphoma of the central nervous system with ocular site. Value of vitrectomy for diagnosis].
    Maalouf T, Angioi-Duprez K, Guibaud I, Baty V, May T, Plenat F, Canton P, George JL.
    J Fr Ophtalmol; 1997 Jun 12; 20(9):693-6. PubMed ID: 9587581
    [Abstract] [Full Text] [Related]

  • 13. [Treatment options in non-Hodgkin lymphomas].
    Tilly H.
    Rev Prat; 2010 Jan 20; 60(1):69-74. PubMed ID: 20222315
    [Abstract] [Full Text] [Related]

  • 14. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
    Cheson BD.
    Clin Adv Hematol Oncol; 2008 Sep 20; 6(9):4-6. PubMed ID: 18998258
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of primary central nervous system lymphoma: still more questions than answers.
    Fine HA.
    Blood; 1995 Oct 15; 86(8):2873-5. PubMed ID: 7579377
    [No Abstract] [Full Text] [Related]

  • 16. Highlights in lymphoma: overview of the 11th International Conference on Malignant Lymphoma.
    Chiappella A, Vitolo U.
    Expert Rev Hematol; 2011 Oct 15; 4(5):491-4. PubMed ID: 21939417
    [Abstract] [Full Text] [Related]

  • 17. [Therapy of Hodgkin disease and non-Hodgkin lymphomas].
    Sréter L.
    Orv Hetil; 2003 Dec 07; 144(49):2429-31. PubMed ID: 14725211
    [No Abstract] [Full Text] [Related]

  • 18. Ocular adnexal lymphoma: evidence-based treatment approach.
    Aronow ME.
    Int Ophthalmol Clin; 2015 Dec 07; 55(1):97-109. PubMed ID: 25436496
    [No Abstract] [Full Text] [Related]

  • 19. Putting caution in TEAM: high-dose chemotherapy with autologous HSCT for primary central nervous system lymphoma.
    Tombleson RL, Green MR, Fancher KM.
    Bone Marrow Transplant; 2012 Oct 07; 47(10):1383-4. PubMed ID: 22426753
    [No Abstract] [Full Text] [Related]

  • 20. Lymphoma researchers in search of molecular targets.
    Friedrich MJ.
    J Natl Cancer Inst; 2010 Jul 21; 102(14):1000-1. PubMed ID: 20616351
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.